TREATMENT OF SPECIFIC NEOPLASMS AND SYNDROMES

Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

TREATMENT OF SPECIFIC NEOPLASMS AND SYNDROMES

Cancer Treatment. Third Edition, Haskell CM, ed. Philadelphia, WB Saunders, p. 121-828, 1990.. Unique Identifier : AIDSLINE ICDB/92680296
Anonymous; No affiliation given

Abstract: Characteristics and therapy of specific neoplasms are reviewed, with emphasis on therapy. Topics include breast cancer; thoracic neoplasms (lung cancer, mesothelioma, and mediastinal tumors); gastrointestinal neoplasms (esophagus, stomach, small bowel, colon and rectum, anus, exocrine pancreas, liver metastases, primary neoplasms of the liver, gallbladder, extrahepatic bile ducts, and ampulla of vater); gynecologic neoplasms (ovary and fallopian tubes, cervix, uterine corpus, vulva, vagina, and gestational trophoblastic neoplasms); head and neck neoplasms (oral cavity and oropharynx, nasal cavity, and paranasal sinuses, nasopharynx, salivary glands, larynx and hypopharynx, and chemotherapy of head and neck cancer); malignant endocrine tumors (multiple endocrine neoplasia, parathyroid glands, thyroid gland, endocrine pancreas, carcinoid tumors, pheochromocytoma, and adrenal cortex); neoplasms of the nervous system (brain and spinal cord); pediatric neoplasms (retinoblastoma, Wilms' tumor, and neuroblastoma); melanoma and skin cancer (melanoma, ocular malignant melanoma, and skin cancer); sarcomas (osteogenic, Ewing's, soft tissue, and vascular); AIDS and AIDS-related neoplasms (AIDS and Kaposi's sarcoma); hematopoietic neoplasms (polycythemia vera and the myeloproliferative syndromes; acute myelogenous leukemia and the myelodysplastic syndromes; acute lymphoblastic, chronic myelogenous, chronic lymphocytic and hairy cell leukemias; myeloma, macroglobulinemia and heavy chain disease; Hodgkin's disease; non-Hodgkin's lymphomas; mycosis fungoides; small noncleaved cell lymphoma [Burkitt's and non-Burkitt's types]; and histiocytic malignancies); genitourinary neoplasms (prostate, bladder cancer, urethra and penis, kidney, and testis); and metastatic disease (metastases of unknown origin, malignant effusions, and superior vena cava syndrome).

Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Female Human Leukemia/*THERAPY Male Neoplasms/*THERAPY Organ Specificity Sarcoma, Kaposi's/ETIOLOGY/THERAPY MONOGRAPH
920630
M9261024

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .